Daily Bulletin

Men's Weekly

.

Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021

- Trial met both primary endpoints demonstrating statistically significant and clinically meaningful extension of progression free survival (PFS) as monotherapy vs. standard of care (SoC) endocrine therapy in overall population and estrogen receptor mutation (mESR1) population

- In the overall population, elacestrant reduced risk of...

Read more: Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021

Business News

Workplace Health Checks: A Smart Investment for Small Business Success

Running a small business means every team member counts and when poor health leads to absenteeism or low energy, productivity and profits take a hit. Lost workdays, rising healthcare costs, and staff ...

Daily Bulletin - avatar Daily Bulletin

Rising Demand: Why Melbourne Needs More Electricians Now

Melbourne is running on change. Rooftops are filling with solar, carports are getting charge points, and older switchboards are being rebuilt so homes and shops can carry smarter, heavier loads. If yo...

Daily Bulletin - avatar Daily Bulletin

What Designers Really Think About Your Current Marketing Collateral

Key Takeaways: Designers notice structure, typography, and colour choices before the content itself Consistency across all collateral strengthens brand recognition and builds trust Overly bu...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals